Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Wan, Baoyu"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Annals of Nuclear Medicine; Mar2023, Vol. 37 Issue 3, p155-165, 11p
Autor:
Wan, Baoyu, Deng, Pengyi, Dai, Wenli, Wang, Peng, Dong, Zhizhi, Yang, Chaojun, Tian, Jinling, Hu, Tao, Yan, Kai
Publikováno v:
Medicine
Background: Programmed cell death ligand 1 (PD-L1), which is highly expressed in a variety of malignant tumors, is closely related to clinicopathological features and prognosis. However, there are few studies on the potential effects of PD-L1 on thyr
Autor:
Baoyu Wan, Pengyi Deng, Wenli Dai, Peng Wang, Zhizhi Dong, Chaojun Yang, Jinling Tian, Tao Hu, Kai Yan, Wan, Baoyu, Deng, Pengyi, Dai, Wenli, Wang, Peng, Dong, Zhizhi, Yang, Chaojun, Tian, Jinling, Hu, Tao, Yan, Kai
Publikováno v:
Medicine; 4/9/2021, Vol. 100 Issue 14, p1-11, 11p
Autor:
Wan B; Department of Nuclear Medicine, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China., Zhang S; Department of Nuclear Medicine, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, China., Wang P; Department of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China., Deng P; Department of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China. dpy@ctgu.edu.cn., Dai W; Department of Nuclear Medicine, The First College of Clinical Medical Science, China Three Gorges University, Yichang, 443000, Hubei, China. daiwenli@ctgu.edu.cn.
Publikováno v:
Annals of nuclear medicine [Ann Nucl Med] 2023 Mar; Vol. 37 (3), pp. 155-165. Date of Electronic Publication: 2022 Dec 17.